ArticlePloS one2014

Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein.

Reem R Al Olaby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.